Influence of sample matrix and storage on BNP measurement on the Bayer Advia Centaur.
Lippi G, Fortunato A, Salvagno GL, Montagnana M, Soffiati G, Guidi GC
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of anticoagulant, blood component, freezing and frozen storage temperature on levels of BNP in plasma and serum. Blood was collected without venous stasis from 32 outpatients.
Summary of Findings
38% and 51% of the BNP found in K2EDTA-plasma was found in serum and lithium heparin-plasma, respectively (both, p<0.05), but significant correlations between BNP levels in K2EDTA-plasma and serum (r=0.978) or lithium heparin-plasma (r=0.987) were observed. After storage for 1 week at -20 degrees C or -80 degrees C, BNP levels decreased by <6% in K2EDTA-plasma and lithium heparin-plasma compared to the corresponding values in fresh plasma (p<0.050), but these changes were smaller than the established mean day-day change in BNP levels (38%). In contrast, serum BNP levels increased by 47% and 28% after 1 week at -20 and -80 degrees C, respectively, compared to levels in fresh specimens.
Biospecimens
FluidPlasmaFluidSerumFluidBloodPreservation Types
FrozenNone (Fresh)Diagnoses
Not specifiedPlatforms
PeptideClinical chemistry/auto analyzerPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant Lithium heparinNonePotassium EDTABiospecimen Aliquots and Components Blood and blood products PlasmaSerumBiospecimen Preservation Type of fixation/preservation FrozenNone (fresh)Storage Storage duration 1 week<2 hStorage Storage temperature -20 degrees C-80 degrees C